INFARINATO ROBERT M. (VP, Chief Financial Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/13/2024ACC: 0001683168-24-006377
Officer· VP, Chief Financial Officer
Since Aug 2024
+3K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 Par Value
Direct
Shares
+3K
Price / share
—
Trade value
—
% of position
37.5%
9/11/2024
8K→11K
Total
Net shares
+3K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value Direct | 9/11/2024 | A · Award | +3K | — | — | 37.5% | 8K | 11K |
| Total | +3K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported